treatment medical

Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre
Pukhraj Rishi, Ekta Rishi, Muna Bhende, Vishvesh Agarwal, Chinmayi H Vyas, Meenakshi Valiveti, Pramod Bhende, Chetan Rao, Pradeep Susvar, Parveen Sen, Rajiv Raman, Vikas Khetan, Vinata Murali, Dhanashree Ratra, Tarun Sharma

British Journal of Ophthalmology Oct 2016, 100 (10) 1337-1340; DOI: 10.1136/bjophthalmol-2015-307802
Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes
Ester Carreño, Tanya Moutray, Konstantinos Fotis, Richard W J Lee, Andrew D Dick, Adam H Ross, Clare Bailey

British Journal of Ophthalmology Sep 2016, 100 (9) 1221-1226; DOI: 10.1136/bjophthalmol-2015-307806
Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy
Taiichi Hikichi, Makoto Higuchi, Takuro Matsushita, Shoko Kosaka, Reiko Matsushita, Kimitaka Takami, Hideo Ohtsuka, Hirokuni Kitamei, Shoko Shioya

British Journal of Ophthalmology May 2013, 97 (5) 617-621; DOI: 10.1136/bjophthalmol-2012-302652
Age-related macular degeneration: choroidal ischaemia?
D Jackson Coleman, Ronald H Silverman, Mark J Rondeau, Harriet O Lloyd, Aziz A Khanifar, R V Paul Chan

British Journal of Ophthalmology Aug 2013, 97 (8) 1020-1023; DOI: 10.1136/bjophthalmol-2013-303143
Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial
Douglas G Day, Thomas R Walters, Gail F Schwartz, Thomas K Mundorf, Charlie Liu, Rhett M Schiffman, Marina Bejanian

British Journal of Ophthalmology Aug 2013, 97 (8) 989-993; DOI: 10.1136/bjophthalmol-2012-303040
Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme
Frank G Holz, Francesco Bandello, Mark Gillies, Paul Mitchell, Aaron Osborne, Tom Sheidow, Eric Souied, Marta S Figueroa, on behalf of the LUMINOUS Steering Committee

British Journal of Ophthalmology Sep 2013, 97 (9) 1161-1167; DOI: 10.1136/bjophthalmol-2013-303232
Efficacy and safety of immunosuppressive agents in the treatment of necrotising scleritis: a retrospective, multicentre study in Korea
Hyun Sun Jeon, Joon Young Hyon, Mee Kum Kim, Tae-Young Chung, Kyung Chul Yoon, Jae Yong Kim, Kyung-Sun Na, Hyung Joon Kim, Tae-Im Kim, Jong Soo Lee, Hyung Keun Lee, Jong Suk Song

British Journal of Ophthalmology Aug 2016, 100 (8) 1066-1070; DOI: 10.1136/bjophthalmol-2015-307462
Mycophenolate sodium for the treatment of chronic non-infectious uveitis of childhood
Deshka Doycheva, Manfred Zierhut, Gunnar Blumenstock, Bianka Sobolewska, Bogomil Voykov, Johanna Hohmann, Martin S Spitzer, Christoph Deuter

British Journal of Ophthalmology Aug 2016, 100 (8) 1071-1075; DOI: 10.1136/bjophthalmol-2015-306701
Dexamethasone intravitreal implant as adjunct therapy for patients with wet age-related macular degeneration with incomplete response to ranibizumab
Pilar Calvo, Antonio Ferreras, Fadwa Al Adel, Yao Wang, Michael H Brent

British Journal of Ophthalmology Jun 2015, 99 (6) 723-726; DOI: 10.1136/bjophthalmol-2014-305684
A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
Robert N Weinreb, Tuyen Ong, Baldo Scassellati Sforzolini, Jason L Vittitow, Kuldev Singh, Paul L Kaufman

British Journal of Ophthalmology Jun 2015, 99 (6) 738-745; DOI: 10.1136/bjophthalmol-2014-305908

Main menu

treatment medical

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

treatment medical

Pages